# Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema

> **NCT01520740** · PHASE4 · TERMINATED · sponsor: **Aeris Therapeutics** · enrollment: 100 (estimated)

## Conditions studied

- Pulmonary Emphysema

## Interventions

- **DEVICE:** Emphysematous Lung Sealant
- **DEVICE:** Emphysematous Lung Sealant

## Key facts

- **NCT ID:** NCT01520740
- **Lead sponsor:** Aeris Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01520740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01520740, "Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01520740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*